Skudlarska B A, Scott G C
Department of Medicine, University of Missouri-Columbia Hospital and Clinics.
Mo Med. 1992 May;89(5):289-93.
More than 7 million Americans suffer from chronic bronchitis, and it has been estimated that each of these patients will experience between one and four acute exacerbations a year. This problem constitutes a major social and financial burden on our society. Despite the prevalence of this disorder there is still considerable disagreement among physicians as to appropriate treatment, especially with regard to the use of antibiotics. Though the role of antibiotics is unclear, the pharmaceutical industry is trying to obtain regulatory approval of several new antibiotics for use in exacerbations of chronic bronchitis. We examine the role of antibiotics in the management of chronic bronchitis.
超过700万美国人患有慢性支气管炎，据估计，这些患者每人每年会经历1至4次急性加重。这个问题给我们的社会带来了重大的社会和经济负担。尽管这种疾病很普遍，但医生们对于适当的治疗方法，尤其是抗生素的使用，仍然存在很大分歧。虽然抗生素的作用尚不清楚，但制药行业正试图获得几种新抗生素用于慢性支气管炎加重期的监管批准。我们研究了抗生素在慢性支气管炎治疗中的作用。
